Page 105 - GPD-4-2

Gene & Protein in Disease Significance of MXRA7 in bladder cancer

doi: 10.1371/journal.pone.0089219 sim380>3.0.co;2-3
16. Lohavanichbutr P, Houck J, Fan W, et al. Genomewide 27. Ritchie ME, Phipson B, Wu D, et al. limma powers
gene expression profiles of HPV-positive and HPV- differential expression analyses for RNA-sequencing and
negative oropharyngeal cancer: Potential implications microarray studies. Nucleic Acids Res. 2015;43(7):e47.
for treatment choices. Arch Otolaryngol Head Neck Surg.
2009;135(2):180-188. doi: 10.1093/nar/gkv007
28. Sherman BT, Hao M, Qiu J, et al. DAVID: A web server
doi: 10.1001/archoto.2008.540
for functional enrichment analysis and functional
17. Holtkamp N, Mautner VF, Friedrich RE, et al. Differentially annotation of gene lists (2021 update). Nucleic Acids Res.
expressed genes in neurofibromatosis 1-associated 2022;50(W1):W216-W221.
neurofibromas and malignant peripheral nerve sheath
tumors. Acta Neuropathol. 2004;107(2):159-168. doi: 10.1093/nar/gkac194
29. Huang DW, Sherman BT, Lempicki RA. Systematic and
doi: 10.1007/s00401-003-0797-8
integrative analysis of large gene lists using DAVID
18. Ganguly A, Shields CL. Differential gene expression profile bioinformatics resources. Nat Protoc. 2009;4(1):44-57.
of retinoblastoma compared to normal retina. Mol Vis.
2010;16:1292-1303. doi: 10.1038/nprot.2008.211
19. Ling Y, Li J, Zhou L. Smoking-related epigenetic modifications 30. Zhang L, Wang Q, Wang L, et al. OSskcm: An online survival
are associated with the prognosis and chemotherapeutics of analysis webserver for skin cutaneous melanoma based on
patients with bladder cancer. Int J Immunopathol Pharmacol. 1085 transcriptomic profiles. Cancer Cell Int. 2020;20:185.
2023;37:3946320231166774. doi: 10.1186/s12935-020-01250-4
doi: 10.1177/03946320231166774 31. Piper Vallillo AJ, Viray H, Feldman J, Rangachari D.
20. Chen Q, Yin G, He X, et al. Establishment and validation of Management of treatment resistance in patients with
a tumor microenvironment prognostic model for predicting advanced epidermal growth factor receptor–mutated lung
bladder cancer survival status based on integrated cancer: Personalization, parsimony, and partnership. J Clin
bioinformatics analyses. Evid Based Complement Alternat Oncol. 2024;42(11):1215-1221.
Med. 2022;2022:4351005. doi: 10.1200/JCO.23.01420
doi: 10.1155/2022/4351005 32. Shen W, Song Z, Zhong X, et al. Sangerbox: A comprehensive,
21. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics interaction-friendly clinical bioinformatics analysis
2020: GLOBOCAN estimates of incidence and mortality platform. iMeta. 2022;1(3):e36.
worldwide for 36 cancers in 185 countries. CA Cancer J Clin. doi: 10.1002/imt2.36
2021;71(3):209-249.
33. Breheny P, Huang PB. High-Dimensional Regression
doi: 10.3322/caac.21660 Modeling: Methodology, Applications, and Software. United
22. Lenis AT, Lec PM, Chamie K. Bladder cancer: A review. States: CRC Press; 2024.
JAMA. 2020;324(19):1980-1991. 34. Kantidakis G, Putter H, Lancia C, de Boer J, Braat AE,
doi: 10.1001/jama.2020.17598 Fiocco M. Survival prediction models since liver
transplantation-comparisons between Cox models and
23. Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. machine learning techniques. BMC Med Res Methodol.
Advances in diagnosis and treatment of bladder cancer. 2020;20:105.
BMJ. 2024;384:e076743.
doi: 10.1186/s12874-020-00997-4
doi: 10.1136/bmj-2023-076743
35. Afrin S, Shamrat FJM, Nibir TI, et al. Supervised
24. Peng M, Xiao D, Bu Y, et al. Novel combination therapies for machine learning based liver disease prediction approach
the treatment of bladder cancer. Front Oncol. 2021;10:539527. with LASSO feature selection. Bull Electr Eng Inform.
doi: 10.3389/fonc.2020.539527 2021;10(6):3369-3376.
25. Zhang B, He Y, Ma G, et al. Identification of stemness index- doi: 10.11591/eei.v10i6.3205
related long noncoding RNA SNHG12 in human bladder 36. Liu D. The Analysis of Junior middle school students’
cancer based on WGCNA. Mol Cell Probes. 2022;66:101867. perceptions regarding English homework from the
doi: 10.1016/j.mcp.2022.101867 perspective of double reduction policy. Trans Comp Educ.
2024;6(5):1-6.
26. Tibshirani R. The lasso method for variable selection in the
Cox model. Stat Med. 1997;16(4):385-395. doi: 10.23977/trance.2024.060501
doi: 10.1002/(sici)1097-0258(19970228)16:4<385::aid- 37. Zhou ZR, Wang WW, Li Y, et al. In-depth mining of clinical

Volume 4 Issue 2 (2025) 10 doi: 10.36922/gpd.6256